Posted inHealth
Moderna and Merck Announce Breakthrough Results in Experimental Melanoma Vaccine Trial
Biotechnology firm Moderna and pharmaceutical giant Merck announced groundbreaking clinical trial results this week, revealing that their experimental messenger RNA (mRNA) cancer vaccine significantly reduces the risk of melanoma recurrence…
